Berlin to go, english edition 2/2015

DISCUSSION
photo: Pfizer
is important to them. Developing and investing in collaborations
is a attitude of Pfizer. Because the pharmaceutical
group is facing new challenges in healthcare IT in
particular. “Digitalisation will change the company and
medicine as a whole. Numerous opportunities will come
about, which will help people to overcome their diseases
on a more personalised and targeted basis. We want to
co-shape this”, says Albiez. At the same time, the company
is working on determining what it can offer based on the
digital patient data already available today. “The Scandinavians
are ahead of us in this area, in particular when it
comes to the legal situation and acceptance by the population”,
explains Peter Albiez. The aim must be to access
data such that treatments can be configured on a more
targeted and sustainable basis, and so that the side effects
profile can be controlled in a more favourable way. Data
protection must always be respected here. “What we wish
to develop for the future are platforms that allow us to
network more strongly with other companies, for example
start-ups – also at international level. This is a challenge
that Pfizer is setting itself.”
Berlin attracts specialists
And the Berlin site must also hold its own within the group
too, in order to generate resources and create the best
opportunities for employees. It is necessary here to make
Germany’s innovation potential even more clearly apparent.
“For this reason too, it is important that we enter into further
collaborations, and strengthen and develop these”,
stresses Albiez.
Incidentally, the group’s German branch is delighted to
play one particular trump card here: Berlin, as an attractive
location for employees. Specialists and highly qualified
personnel are happy to come here. Because the city draws
talented employees from around the world with its open and
cosmopolitan setting. The company’s head office, close to
Potsdamer Platz and therefore right at the heart of Berlin,
has particularly strong appeal. “For us it’s great that we can
recruit top personnel for our company in this way”, enthuses
Peter Albiez – clearly delighted with the “Berlin Effect”. gsk
Pfizer – Facts, figures and data
• Over 10,000 researchers
• Around 80,000 employees worldwide
• The world‘s most renowned prescription-free products:
ThermaCare, VitaSprint and Centrum.
• Focuses of research: Cancerous diseases, pain, inflammatory
diseases and diseases of the central nervous
system, vaccines.
• In Germany, Pfizer currently employs over 2,000 staff
members at three sites: Berlin, Freiburg and Karlsruhe.
The head office of Pfizer Germany in Berlin is home to
the human medicine and consumer healthcare divisions.
Furthermore, Pfizer controls its cancer division
for Europe, Africa, the Middle East, and the regions of
Greater China and Asia-Pacific from Berlin.
BERLIN TO GO 15